Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lodi

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Plos One|November 10, 2022
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversionCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
AIDS (London, England)|July 18, 2022
Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIVGuilin Li, Lesley S Park, Sara Lodi, et al.
The Journal of Infectious Diseases|August 22, 2022
Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate BiasJacquelyn Turcinovic, Beau Schaeffer, Bradford P Taylor, et al.
Eclinicalmedicine|January 27, 2025
Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trialWinnie R Muyindike, Robin Fatch, Sara Lodi, et al.
Trials|May 21, 2021
The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trialSara Lodi, Nneka I Emenyonu, Kara Marson, et al.
Open Forum Infectious Diseases|June 30, 2021
Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?Rachel L Epstein, Heather Sperring, Melissa Hofman, et al.
Journal of the American Heart Association|August 9, 2019
Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival TimesSarah C Conner, Sara Lodi, Kathryn L Lunetta, et al.
Contemporary Clinical Trials Communications|December 10, 2021
Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, RussiaSarah L Rossi, Yuliia Sereda, Jason B Luoma, et al.
AIDS (London, England)|October 27, 2016
The per-protocol effect of immediate versus deferred antiretroviral therapy initiationSara Lodi, Shweta Sharma, Jens D Lundgren, et al.
The American Journal of Drug and Alcohol Abuse|September 4, 2025
Associations between COVID impact domains and time to buprenorphine treatment disengagementZoe M Weinstein, Kara M Magane, Sara Lodi, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Plos One|November 10, 2022
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversionCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
AIDS (London, England)|July 18, 2022
Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIVGuilin Li, Lesley S Park, Sara Lodi, et al.
The Journal of Infectious Diseases|August 22, 2022
Understanding Early Pandemic Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Medical Center by Incorporating Public Sequencing Databases to Mitigate BiasJacquelyn Turcinovic, Beau Schaeffer, Bradford P Taylor, et al.
Eclinicalmedicine|January 27, 2025
Alcohol use and HIV suppression after completion of financial incentives for alcohol abstinence and isoniazid adherence: a randomized controlled trialWinnie R Muyindike, Robin Fatch, Sara Lodi, et al.
Trials|May 21, 2021
The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trialSara Lodi, Nneka I Emenyonu, Kara Marson, et al.
Open Forum Infectious Diseases|June 30, 2021
Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?Rachel L Epstein, Heather Sperring, Melissa Hofman, et al.
Journal of the American Heart Association|August 9, 2019
Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival TimesSarah C Conner, Sara Lodi, Kathryn L Lunetta, et al.
Contemporary Clinical Trials Communications|December 10, 2021
Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, RussiaSarah L Rossi, Yuliia Sereda, Jason B Luoma, et al.
AIDS (London, England)|October 27, 2016
The per-protocol effect of immediate versus deferred antiretroviral therapy initiationSara Lodi, Shweta Sharma, Jens D Lundgren, et al.
The American Journal of Drug and Alcohol Abuse|September 4, 2025
Associations between COVID impact domains and time to buprenorphine treatment disengagementZoe M Weinstein, Kara M Magane, Sara Lodi, et al.
Pageof 11